Abstract
Significant racial disparities in utilization and outcomes of novel cardiovascular procedures have been previously reported. Transcatheter aortic valve replacement (TAVR) has recently become the mainstay of treatment for patients with severe aortic stenosis who are not surgical candidates. Data on
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
